Bullboard - Stock Discussion Forum Claritas Pharmaceuticals Inc V.CLAS.H

Alternate Symbol(s): CLAZF

Healthcare

Claritas Pharmaceuticals, Inc., formerly Kalytera Therapeutics Inc, is a biotechnology company that is focused on developing R-107 for the treatment of vaccine-resistant coronavirus disease (COVID) strains. The Company’s products in development include R-107 for coronavirus disease and Viral Infections, R-107 and Vaccines, and CLA-1816 for treatment of pain. R-107 is designed to defeat COVID... see more

Add To Watchlist

TSXV:CLAS.H - Post Discussion

Claritas Pharmaceuticals Inc > Off Topic

View:

Post by Red~One on Aug 16, 2022 9:59am

Off Topic

Regarding CLAS: Is it possible that without meeting any Milestones that Claritas/Robert Farewell is in danger of losing Licences for R107 from the Salzman Team, losing any further payments from Obsidian etc and even jeopardizes his tax rebate/status from the Aussie government since there is no active research and development going on this year?

143